As a triple agonist targeting GLP-1, GIP, and glucagon receptors, retatrutide offers a mechanism uniquely suited to bodybuilding goals: - **GLP-1 receptor:** Reduces appetite and food intake essential for getting slim during a cutting phase - **GIP receptor:** May support lean mass preservation and nutrient partitioning relevant for muscle building goals - **Glucagon receptor:** Directly increases metabolic rate and fat oxidation a mechanism no GHRP bodybuilding peptide could match Phase 2 trial data published in *The Lancet* showed **up to 24.2% body weight reduction** with retatrutide the highest of any peptide injection studied to date
14 mg dose After at least 30 days taking the 7 mg dose, your healthcare professional may prescribe the 14 mg dose if more blood sugar control is needed
Triple-pathway research requires retatrutide
The Regions Weight Loss Specialist: With over 25 years of proven clinical experience, Dr
Foundayo is "enzymatically stable," meaning it doesn't get "digested" like a protein
GLOBAL GLUTATHIONE MARKET SIZE, 2018-2032 (USD MILLION) TABLE 2
